Skip to main content
Premium Trial:

Request an Annual Quote

Biological Dynamics Gets $1M Grant to Advance TB Test

NEW YORK — Biological Dynamics said on Thursday that it has received roughly $1 million in new funding from the Bill and Melinda Gates Foundation to support the continued development of a tuberculosis (TB) detection assay.

The test is based on the same alternating current electrokinetic technology underlying the firm's Verita lab-on-a-chip platform, using an alternating current to create a non-uniform electric field that can capture particles within particular size ranges while repelling those that are smaller or larger.

With an earlier $500,000 grant from the Gates Foundation, Biological Dynamics established the feasibility of on-chip detection of serum exosomal biomarkers associated with TB. The San Diego-based firm said that the new funding will be used to optimize the assay and will establish its performance in a case-controlled study testing clinical samples collected in resource-poor settings.

"Working with the foundation connected us to a global ecosystem of scientists and [low- and middle-income country]-based medical practitioners, whose insights are invaluable for advancing our work," Biological Dynamics Founder and CEO Raj Krishnan said in a statement. "The sensitivity, scalability, and affordability of our Verita-powered workflow makes it ideal for developing tests intended for resource-poor settings."

In addition to TB, Biological Dynamics is developing the Verita system for the detection of biomarkers linked to pancreatic cancer, glioblastoma, and Alzheimer's disease.

The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.